Industry’s first unified cloud solution breaks down silos in quality
management, connects end-to-end processes across all global stakeholders
PLEASANTON, Calif.--(BUSINESS WIRE)--
Veeva Systems (NYSE:VEEV) today unveiled the industry’s first cloud
application that unifies quality management processes in life sciences. Veeva
Vault QMS replaces disparate, on-premise systems to manage global
quality processes across an organization, including external partners.
Together with Veeva
Vault QualityDocs, Veeva now offers the only integrated suite of
quality applications for seamless end-to-end content and quality
management, delivering greater visibility and collaboration.
“Quality management solutions are crucial to ensuring product safety and
ongoing regulatory compliance,” said Robert Lorence, vice president,
Quality and Compliance Services at HighPoint Solutions. “Veeva's new QMS
application offers the market a powerful, modern, cloud alternative to
existing on-premise quality management systems. In an industry segment
continually looking for greater efficiency and effectiveness, this is
welcome news.”
Increased global outsourcing of quality manufacturing, combined with
intensified regulatory scrutiny, is fueling complexity in the life
sciences industry. While the majority of companies have implemented a
quality management system, these solutions often reside – and are only
accessible – within a company’s four walls1. This limits
visibility and access throughout the entire global supply chain for
critical stakeholders, especially external contract manufacturers and
partners.
Veeva solves this with a suite of cloud applications – Vault QMS and
Vault QualityDocs – that brings together quality processes and
documentation throughout the enterprise. The new Vault QMS application
incorporates external stakeholders into the full spectrum of quality
processes, including deviations, lab investigations, complaints,
internal and external audits, corrective and preventive actions, and
change control. This reduces compliance risks and eliminates bottlenecks
in bringing drugs and treatments to market.
“Quality management is more complicated today, involves more people and
geographies, and requires greater transparency for regulatory
authorities,” said Michael Jovanis, vice president of Veeva Vault
Quality. “Customers struggle to keep quality processes and documentation
in sync and incorporate external partners with disparate systems. Vault
QMS meets the realities of today’s quality manufacturing environment and
connects the entire end-to-end quality process.”
Veeva Vault QMS is the latest application built on Veeva
Vault, a cloud platform and suite of applications that provide a
single source of truth across the enterprise. Native interoperability
between Vault applications empowers life sciences companies to
streamline their business processes across an increasingly broad
ecosystem of internal and external stakeholders.
Veeva Vault QMS will be available in late June 2016. To learn more about
how cloud–based quality solutions are modernizing quality management, register
for the upcoming webinar, “Modernizing Quality Management,” and see a
live demonstration of Vault QMS on July 14, 2016.
Additional Information
For more on Veeva Vault QMS, visit: veeva.com/QMS.
For
more on the Veeva suite of quality products, visit: veeva.com/quality.
Stay
updated on the latest Veeva news on LinkedIn: linkedin.com/company/veeva-systems.
Follow
@veevasystems on Twitter: twitter.com/veevasystems.
Like
Veeva on Facebook: facebook.com/veevasystems.
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 400 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit www.veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-K for the period ended January 31, 2016. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160526005400/en/
Source: Veeva Systems